Calò P.
- Country
- Belgium
- Department
- Hématologie et oncologie pédiatrique
Research Overview
- Evaluation of Chemotherapy Regimens Including Cisplatin, Cyclophosphamide, and Etoposide in Pediatric and Young Adult Ependymoma Treatment
- Evaluation of Hyperfractionated-Accelerated Radiotherapy and High-Dose Thiotepa Therapy in High-Risk Medulloblastoma Patients Aged Over 3 Years
- Neurocognitive Outcomes in Low-Risk Medulloblastoma: Methotrexate, Etoposide, Cyclophosphamide, Carboplatin, Vincristine, Cisplatin, and Thiotepa Evaluation
Data & Insights
Has run more than one trial at 82 of 156 partner sites.
Specializations
Pediatric Hematologic Malignancies
Dedicated to the study of blood‑derived cancers and related disorders in children, emphasizing disease biology and therapeutic strategies.
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Lymphoblastic Lymphoma
- Chronic graft‑versus‑host disease
- Relapsed Acute Lymphoblastic Leukemia
Based at University Children’s Hospital Queen Fabiola in Brussels, Belgium.
Pediatric Solid Tumors
Focuses on embryonal and sarcomatous neoplasms that affect the pediatric population, seeking improvements in survival and quality of life.
- Neuroblastoma
- Medulloblastoma
- Ewing Sarcoma
- Atypical teratoid/rhabdoid tumour
- Rhabdomyosarcoma
Clinical investigations are conducted within the University Children’s Hospital Queen Fabiola network.
Transplant Immunology and Viral Complications
Addresses immune reconstitution, graft‑versus‑host disease, and viral infections that arise after hematopoietic or solid‑organ transplantation in pediatric patients.
- Cytomegalovirus infection in transplant recipients
- EBV‑associated post‑transplant lymphoproliferative disease
- Graft‑versus‑host disease (acute and chronic)
- Conditioning regimens for pediatric stem‑cell transplantation
- Immune monitoring after allogeneic transplantation
Research is coordinated through the pediatric hemato‑oncology department at the University Children’s Hospital Queen Fabiola.
Metabolic, Genetic and Rare Diseases
Targets inherited metabolic disorders and ultra‑rare genetic conditions, aiming to develop disease‑modifying therapies for children.
- Duchenne Muscular Dystrophy
- Spinal Muscular Atrophy
- Hypophosphatasia
- Urea cycle disorders
- Crigler‑Najjar syndrome
Studies are carried out at the University Children’s Hospital Queen Fabiola, leveraging its expertise in rare pediatric diseases.
Inflammatory and Autoimmune Disorders
Specializes in chronic inflammatory and autoimmune conditions affecting children, with an emphasis on novel biologic and small‑molecule interventions.
- Ulcerative Colitis
- Crohn’s Disease
- Atopic Dermatitis
- Juvenile Psoriatic Arthritis
- Severe hemophilia A and B
Clinical programs are integrated within the pediatric hemato‑oncology service at University Children’s Hospital Queen Fabiola.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.